{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:29:17Z","timestamp":1786580957872,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Provincial Rising Medical Talent under the Zhejiang Provincial High-Level Talent Special Support Program","award":["2023-88"],"award-info":[{"award-number":["2023-88"]}]},{"name":"Taizhou Special Support Plan for High-Level Talents","award":["TZ2022-2"],"award-info":[{"award-number":["TZ2022-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mortality among people with HIV (PWH) increasingly reflects both HIV-related and non-HIV-related causes. Whether a simple index integrating routinely measured kidney and immune function can improve risk stratification remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study in Taizhou, Zhejiang, China using the China HIV\/AIDS Comprehensive Response Information Management System linked to a cause-of-death surveillance system. Adults aged\u2009\u2265\u200918 years diagnosed with HIV between 1998 and 2024 who had at least one paired serum creatinine and CD4 measurement were followed through 31 December 2024. Time-updated estimated glomerular filtration rate (eGFR), CD4, and a combined eGFR-CD4 index (CBI) were analysed using time-dependent Cox models. Restricted cubic splines assessed non-linearity, and 12-month landmark analyses with time-dependent receiver operating characteristic curves evaluated discrimination. Bootstrap internal validation was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 3683 PWH (median follow-up 5.61 years), 434 deaths occurred, including 67 HIV-related and 367 non-HIV-related deaths. Each 1-SD increase in CBI was associated with higher risks of all-cause, HIV-related, and non-HIV-related mortality, with adjusted hazard ratios of 4.12 (95% CI: 2.76\u20136.15), 37.86 (95% CI: 9.03\u2013158.80), and 3.30 (95% CI: 2.20\u20134.93), respectively (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Landmark analyses showed graded risk separation across CBI quartiles. After bootstrap internal validation, the combined model showed modestly higher discrimination for all-cause and non-HIV-related mortality, whereas CD4 alone performed best for HIV-related mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A time-varying combined eGFR-CD4 index was associated with mortality outcomes in this cohort of PWH in Taizhou, Zhejiang, China. Its discriminatory advantage after internal validation was modest and was evident for all-cause and non-HIV-related, but not HIV-related, mortality. External validation is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-026-00894-1","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T21:33:40Z","timestamp":1780868020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A combined eGFR-CD4 index and mortality risk among people with HIV: a retrospective cohort study in Taizhou city, Zhejiang province, China"],"prefix":"10.1186","volume":"23","author":[{"given":"Congcong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tailin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"894_CR1","unstructured":"World Health Organization. HIV data and statistics.\u00a0Accessed 2 Feb 2026.\u00a0https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics"},{"key":"894_CR2","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). FACT SHEET 2025: Latest global and regional statistics on the status of the AIDS epidemic.\u00a0Accessed 2 Feb 2025."},{"issue":"3","key":"894_CR3","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/S2352-3018(23)00272-2","volume":"11","author":"A Trickey","year":"2024","unstructured":"Trickey A, McGinnis K, Gill MJ, et al. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies. Lancet HIV. 2024;11(3):e176\u201385.","journal-title":"Lancet HIV"},{"issue":"5","key":"894_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/cid\/ciae228","volume":"79","author":"E Tusch","year":"2024","unstructured":"Tusch E, Ryom L, Pelchen-Matthews A, et al. Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration. Clin Infect Dis. 2024;79(5):1242\u201357.","journal-title":"Clin Infect Dis"},{"issue":"48","key":"894_CR5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.46234\/ccdcw2023.201","volume":"5","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Wei L, Dou Z, et al. Changing Mortality and Patterns of Death Causes in HIV Infected Patients - China, 2013\u20132022. China CDC Wkly. 2023;5(48):1073\u20138.","journal-title":"China CDC Wkly"},{"issue":"1","key":"894_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12882-023-03159-5","volume":"24","author":"M Hunter-Dickson","year":"2023","unstructured":"Hunter-Dickson M, Drak D, Anderson M, et al. Comparison of CG, CKD-EPI[AS] and CKD-EPI[ASR] equations to estimate glomerular filtration rate and predict mortality in treatment naive people living with HIV in Zimbabwe. BMC Nephrol. 2023;24(1):129.","journal-title":"BMC Nephrol"},{"issue":"4","key":"894_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/j.ajkd.2012.03.006","volume":"60","author":"F Ibrahim","year":"2012","unstructured":"Ibrahim F, Hamzah L, Jones R, et al. Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients. Am J Kidney Dis. 2012;60(4):539\u201347.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"894_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/QAD.0000000000003153","volume":"36","author":"D Drak","year":"2022","unstructured":"Drak D, Shamu T, Heron JE, Chimbetete C, Dahwa R, Gracey DM. Renal function and associated mortality risk in adults commencing HIV antiretroviral therapy in Zimbabwe. AIDS. 2022;36(5):631\u20136.","journal-title":"AIDS"},{"issue":"5","key":"894_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/QAD.0000000000000134","volume":"28","author":"A Mocroft","year":"2014","unstructured":"Mocroft A, Ryom L, Begovac J, et al. Deteriorating renal function and clinical outcomes in HIV-positive persons. AIDS. 2014;28(5):727\u201337.","journal-title":"AIDS"},{"key":"894_CR10","doi-asserted-by":"publisher","first-page":"1502804","DOI":"10.3389\/fmed.2025.1502804","volume":"12","author":"R Sun","year":"2025","unstructured":"Sun R, Jia H, Kang Q, et al. Non-linear association between CD4\u2009+\u2009T-cell counts and mortality risk in people living with HIV: evidence from a 10-year cohort study. Front Med (Lausanne). 2025;12:1502804.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"894_CR11","doi-asserted-by":"publisher","first-page":"e1001194","DOI":"10.1371\/journal.pmed.1001194","volume":"9","author":"H I.V.E.R.i.E.i.E","year":"2012","unstructured":"Opportunistic Infections Project Team of the Collaboration of Observational, I.V.E.R.i.E.i.E H, Young J, Psichogiou M, et al. CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med. 2012;9(3):e1001194.","journal-title":"PLoS Med"},{"issue":"2","key":"894_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/cid\/ciab883","volume":"75","author":"KA McGinnis","year":"2022","unstructured":"McGinnis KA, Justice AC, Moore RD, et al. Discrimination and Calibration of the Veterans Aging Cohort Study Index 2.0 for Predicting Mortality Among People With Human Immunodeficiency Virus in North America. Clin Infect Dis. 2022;75(2):297\u2013304.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"894_CR13","first-page":"ii79","volume":"39","author":"Y Mao","year":"2010","unstructured":"Mao Y, Wu Z, Poundstone K, et al. Development of a unified web-based national HIV\/AIDS information system in China. Int J Epidemiol. 2010;39(Suppl 2):ii79\u201389.","journal-title":"Int J Epidemiol"},{"issue":"19","key":"894_CR14","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"24","key":"894_CR15","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1001\/jama.2024.4970","volume":"331","author":"PC Austin","year":"2024","unstructured":"Austin PC, Ibrahim M, Putter H. Accounting for Competing Risks in Clinical Research. JAMA. 2024;331(24):2125\u20136.","journal-title":"JAMA"},{"key":"894_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.publhealth.20.1.145","volume":"20","author":"LD Fisher","year":"1999","unstructured":"Fisher LD, Lin DY. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health. 1999;20:145\u201357.","journal-title":"Annu Rev Public Health"},{"issue":"30","key":"894_CR17","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381\u201397.","journal-title":"Stat Med"},{"issue":"4","key":"894_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41409-019-0679-x","volume":"55","author":"J Gauthier","year":"2020","unstructured":"Gauthier J, Wu QV, Gooley TA. Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians. Bone Marrow Transpl. 2020;55(4):675\u201380.","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"894_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u20137.","journal-title":"Ann Intern Med"},{"key":"894_CR20","doi-asserted-by":"publisher","first-page":"101600","DOI":"10.1016\/j.eclinm.2022.101600","volume":"52","author":"R Martin-Iguacel","year":"2022","unstructured":"Martin-Iguacel R, Reyes-Uruena J, Bruguera A, et al. Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study. EClinicalMedicine. 2022;52:101600.","journal-title":"EClinicalMedicine"},{"key":"894_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100175","author":"Y Caro-Vega","year":"2022","unstructured":"Caro-Vega Y, Rebeiro PF, Shepherd BE, et al. Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study. Lancet Reg Health. 2022. https:\/\/doi.org\/10.1016\/j.lana.2021.100175.","journal-title":"Lancet Reg Health"},{"issue":"5","key":"894_CR22","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","volume":"10","author":"A Trickey","year":"2023","unstructured":"Trickey A, Sabin CA, Burkholder G, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023;10(5):e295\u2013307.","journal-title":"Lancet HIV"},{"key":"894_CR23","doi-asserted-by":"publisher","DOI":"10.1056\/evidoa2200302","author":"JD Lundgren","year":"2023","unstructured":"Lundgren JD, Babiker AG, Sharma S, et al. Long-term benefits from early antiretroviral therapy initiation in HIV Infection. NEJM Evid. 2023. https:\/\/doi.org\/10.1056\/evidoa2200302.","journal-title":"NEJM Evid"},{"issue":"2","key":"894_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11904-023-00645-1","volume":"20","author":"CE Cervantes","year":"2023","unstructured":"Cervantes CE, Atta MG. Updates on HIV and Kidney Disease. Curr HIV\/AIDS Rep. 2023;20(2):100\u201310.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"894_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41581-023-00801-1","volume":"20","author":"NE Diana","year":"2024","unstructured":"Diana NE, Naicker S. The changing landscape of HIV-associated kidney disease. Nat Rev Nephrol. 2024;20(5):330\u201346.","journal-title":"Nat Rev Nephrol"},{"issue":"13","key":"894_CR26","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","volume":"330","author":"ME D.P.C","year":"2023","unstructured":"Writing Group for the, C.K, D.P.C. ME, Grams J, Coresh, et al. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. JAMA. 2023;330(13):1266\u201377.","journal-title":"JAMA"},{"key":"894_CR27","doi-asserted-by":"publisher","first-page":"100662","DOI":"10.1016\/j.eclinm.2020.100662","volume":"29\u201330","author":"BJ Nankivell","year":"2020","unstructured":"Nankivell BJ, Nankivell LFJ, Elder GJ, Gruenewald SM. How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy. EClinicalMedicine. 2020;29\u201330:100662.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"894_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41581-019-0191-y","volume":"16","author":"AS Levey","year":"2020","unstructured":"Levey AS, Coresh J, Tighiouart H, Greene T, Inker LA. Measured and estimated glomerular filtration rate: current status and future directions. Nat Rev Nephrol. 2020;16(1):51\u201364.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"894_CR29","doi-asserted-by":"publisher","first-page":"ofae333","DOI":"10.1093\/ofid\/ofae333","volume":"11","author":"J Ambia","year":"2024","unstructured":"Ambia J, Ingle SM, McGinnis K, et al. Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America. Open Forum Infect Dis. 2024;11(7):ofae333.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"894_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/QAD.0b013e32835b8c7f","volume":"27","author":"JP Tate","year":"2013","unstructured":"Tate JP, Justice AC, Hughes MD, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013;27(4):563\u201372.","journal-title":"AIDS"},{"issue":"5","key":"894_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/QAD.0000000000002140","volume":"33","author":"JP Tate","year":"2019","unstructured":"Tate JP, Sterne JAC, Justice AC. Veterans Aging Cohort, and C. the Antiretroviral Therapy Cohort, Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals. AIDS. 2019;33(5):903\u201312.","journal-title":"AIDS"},{"issue":"2","key":"894_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/aje\/kwp107","volume":"170","author":"B Lau","year":"2009","unstructured":"Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244\u201356.","journal-title":"Am J Epidemiol"},{"issue":"27","key":"894_CR33","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP. Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. 2017;36(27):4391\u2013400.","journal-title":"Stat Med"},{"issue":"6","key":"894_CR34","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/jac\/dkae116","volume":"79","author":"RL Batterham","year":"2024","unstructured":"Batterham RL, Bedimo RJ, Diaz RS, et al. Cardiometabolic health in people with HIV: expert consensus review. J Antimicrob Chemother. 2024;79(6):1218\u201333.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 5","key":"894_CR35","doi-asserted-by":"publisher","first-page":"e25791","DOI":"10.1002\/jia2.25791","volume":"24","author":"HH Kyu","year":"2021","unstructured":"Kyu HH, Jahagirdar D, Cunningham M, et al. Accounting for misclassified and unknown cause of death data in vital registration systems for estimating trends in HIV mortality. J Int AIDS Soc. 2021;24(Suppl 5):e25791.","journal-title":"J Int AIDS Soc"},{"key":"894_CR36","doi-asserted-by":"publisher","first-page":"c117","DOI":"10.1136\/bmj.c117","volume":"340","author":"X Sun","year":"2010","unstructured":"Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010;340:c117.","journal-title":"BMJ"},{"issue":"1","key":"894_CR37","doi-asserted-by":"publisher","first-page":"e1004325","DOI":"10.1371\/journal.pmed.1004325","volume":"21","author":"KN Althoff","year":"2024","unstructured":"Althoff KN, Stewart C, Humes E, et al. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: a modeling study. PLoS Med. 2024;21(1):e1004325.","journal-title":"PLoS Med"},{"issue":"3","key":"894_CR38","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1016\/S2352-3018(22)00400-3","volume":"10","author":"E Verheij","year":"2023","unstructured":"Verheij E, Boyd A, Wit FW, et al. Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGE(h)IV cohort study. Lancet HIV. 2023;10(3):e164\u201374.","journal-title":"Lancet HIV"},{"issue":"9","key":"894_CR39","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/infdis\/jit043","volume":"207","author":"L Ryom","year":"2013","unstructured":"Ryom L, Mocroft A, Kirk O, et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis. 2013;207(9):1359\u201369.","journal-title":"J Infect Dis"},{"issue":"1","key":"894_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cit757","volume":"58","author":"JA Aberg","year":"2014","unstructured":"Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58(1):1\u201310.","journal-title":"Clin Infect Dis"},{"issue":"22","key":"894_CR41","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1097\/CM9.0000000000003383","volume":"137","author":"S o.I.D.C.M.A","year":"2024","unstructured":"Acquired Immunodeficiency Syndrome Professional Group, o.I.D.C.M.A S. Chinese Center for Disease, and Prevention, Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection\/acquired immunodeficiency syndrome (2024 edition). Chin Med J (Engl). 2024;137(22):2654\u201380.","journal-title":"Chin Med J (Engl)"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00894-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00894-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00894-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:02:11Z","timestamp":1786579331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00894-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00894-1","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Taizhou City Center for Disease Control and Prevention and the Taizhou Municipal Institute of Health Supervision, Taizhou, Zhejiang, China (approval number: TZCDC-2025-IIR-011). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from the participants.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"76"}}